This content is machine translated Study report Vitiligo: disease burden and care needs Today, there are several treatment options that have been shown to improve disease and symptom control in vitiligo. However, there appear to be certain gaps in treatment in everyday clinical…
View Post 18 min This content is machine translated Chronic hand eczema Challenges in day-to-day care An updated version of the s2k guideline “Diagnosis, prevention and treatment of hand eczema” was published in 2023. It is proposed to classify hand eczema/chronic hand eczema from an etiological… CME-Test
View Post 5 min This content is machine translated Lichen sclerosus Topical corticosteroids still the first choice Anogenital itching and clinical features such as redness, white skin changes and fissures are possible indications of lichen sclerosus. In 2023, an update of the European Dermatology Forum guideline on…
View Post 6 min This content is machine translated Atopic dermatitis in children Early and proactive therapy – case studies from the children’s hospital The psychosocial level plays an important role in the successful treatment of atopic dermatitis. With regard to anti-inflammatory treatment, addressing treatment anxiety is an important factor. Both topical corticosteroids and…
View Post 6 min This content is machine translated Alopecia areata: drug therapy Which method achieves the best hair growth rates? Alopecia areata (AA) manifests as acute or chronic non-scarring hair loss. Diphenylcyclopropenone and Janus kinase inhibitors have a significantly higher remission rate compared with the spontaneous course, especially in severe…
View Post 4 min This content is machine translated Atopic dermatitis Topical calcineurin inhibitors: Facts and myths Calcineurin inhibitors can be used in atopic dermatitis as monotherapy or combined with topical corticosteroids. Tacrolimus and pimecrolimus do not cause skin atrophy even with long-term use. Which treatment regimen…
View Post 3 min This content is machine translated Atopic dermatitis Dupilumab not only reduces primary symptoms Comorbid psychological symptoms are common in atopic dermatitis and can have serious consequences. The IgG4 monoclonal antibody dupilumab led to significant symptom reduction in subpopulations of this patient population, resulting…
